Prediction of Recurrence for Advanced Breast Cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (172)
Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
1987 • 11,429 citations
pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up
1991 • 5,979 citations
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
1991 • 5,657 citations
Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases
1989 • 2,245 citations
The p53 proto-oncogene can act as a suppressor of transformation
1989 • 2,019 citations
Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells
1986 • 1,903 citations
Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast Carcinoma
1992 • 1,799 citations
Molecular themes in oncogenesis
1991 • 1,663 citations
A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors
1989 • 1,471 citations
Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells
1984 • 1,416 citations
Evidence for a Novel Gene Associated With Low Tumor Metastatic Potential
1988 • 1,304 citations
Diagnostic Histopathology of the Breast
1988 • 1,083 citations
The Nottingham prognostic index in primary breast cancer
1992 • 1,051 citations
Cell Surface P-Glycoprotein Associated with Multidrug Resistance in Mammalian Cell Lines
1983 • 1,001 citations
Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast Cancer
1988 • 921 citations
EPIDERMAL-GROWTH-FACTOR RECEPTOR STATUS AS PREDICTOR OF EARLY RECURRENCE OF AND DEATH FROM BREAST CANCER
1987 • 881 citations
Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer
1992 • 822 citations
Treatment of Early-Stage Breast Cancer
1991 • 763 citations
Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers
1992 • 757 citations
The value of estrogen and progesterone receptors in the treatment of breast cancer
1980 • 735 citations
Cloning of the human estrogen receptor cDNA.
1985 • 720 citations
Multiple-Drug Resistance in Human Cancer
1987 • 703 citations
A prognostic index in primary breast cancer
1982 • 687 citations
A receptor molecule for estrogens: isolation from the rat uterus and preliminary characterization.
1966 • 680 citations
Assessment of response to therapy in advanced breast cancer.A project of the programme on clinical oncology of the International Union against Cancer, Geneva, Switzerland
1977 • 633 citations
Estrogen Receptors in Human Breast Cancer
1976 • 621 citations
Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer.
1990 • 602 citations
HER-2/neu oncogene protein and prognosis in breast cancer.
1989 • 579 citations
Prediction of Relapse or Survival in Patients with Node-Negative Breast Cancer by DNA Flow Cytometry
1989 • 571 citations
Predicting Response to Endocrine Therapy in Human Breast Cancer: A Hypothesis
1975 • 570 citations
Microvessel quantitation and prognosis in invasive breast carcinoma
1992 • 566 citations
Adjuvant Therapy of Cancer
1990 • 534 citations
Cancer of the breast: Size of neoplasm and prognosis
1969 • 491 citations
HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma.
1992 • 466 citations
Complete amino acid sequence of the human progesterone receptor deduced from cloned cDNA
1987 • 419 citations
Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06.
1988 • 415 citations
A Randomized Clinical Trial Evaluating Sequential Methotrexate and Fluorouracil in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor-Negative Tumors
1989 • 400 citations
A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma.
1989 • 385 citations
Progesterone Receptors as a Prognostic Factor in Stage II Breast Cancer
1983 • 372 citations
Ten year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy.
1975 • 367 citations
Heat Shock Protein hsp70 in Patients With Axillary Lymph Node-Negative Breast Cancer: Prognostic Implications
1993 • 361 citations
Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis.
1987 • 360 citations
Efficacy of Adjuvant Chemotherapy in High-Risk Node-Negative Breast Cancer
1989 • 359 citations
Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years.
1989 • 357 citations
Breast cancer: Relationship between the size of the primary tumour and the probability of metastatic dissemination
1984 • 354 citations
Association of Overexpression of Tumor Suppressor Protien p53 With Rapid Cell Proliferation and Poor Prognosis in Node-Negative Breast Cancer Patients
1992 • 349 citations
Indicators of Prognosis in Node-Negative Breast Cancer
1990 • 348 citations
CATHEPSIN D: AN INDEPENDENT PROGNOSTIC FACTOR FOR METASTASIS OF BREAST CANCER
1989 • 327 citations
Inhibition of human mammary and prostatic cancers by adrenalectomy.
1952 • 327 citations
Micrometastases to axillary lymph nodes from carcinoma of breast: Detection by immunohistochemistry and prognostic significance
1987 • 311 citations
DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens
1988 • 301 citations
Expression of the Antimetastatic Gene nm23 in Human Breast Cancer: An Association WIth Good Prognosis
1991 • 298 citations
Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer.
1987 • 263 citations
Ki-67 immunostaining in human breast tumors and its relationship to prognosis
1991 • 258 citations
Pathologic findings from the national surgical adjuvant project for breast cancers (protocol no. 4) X. Discriminants for tenth year treatment failure
1984 • 252 citations
Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer.
1989 • 250 citations
Maintenance of p53 alterations throughout breast cancer progression.
1991 • 244 citations
Localization of Progesterone Receptor with Monoclonal Antibodies to the Human Progestin Receptor*
1988 • 230 citations
Prediction of early course of breast carcinoma by thymidine labeling
1983 • 230 citations
Steroid receptors and other prognostic factors in primary breast cancer.
1988 • 227 citations
Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction: A proposed classification of DNA histograms in breast cancer
1988 • 226 citations
The long‐term prognostic significance of the thymidine labelling index in breast cancer
1984 • 225 citations
Nuclear structure in cancer tissues.
1957 • 222 citations
Mitosis counting in tumors
1990 • 213 citations
Histologic grading of breast carcinoma. A reproducibility study
1994 • 212 citations
Risk of Internal Mammary Lymph Node Metastases and Its Relevance on Prognosis of Breast Cancer Patients
1983 • 211 citations
Consensus review of the clinical utility of dna cytometry in carcinoma of the breast
1993 • 196 citations
Epidermal growth factor receptors in human breast cancer
1984 • 190 citations
Prognosis in Carcinoma of the Breast
1950 • 184 citations
Monoclonal antibodies as probes for estrogen receptor detection and characterization
1982 • 181 citations
Histologic grading of breast cancer.
1980 • 177 citations
Tumour DNA ploidy as an independent prognostic factor in breast cancer
1987 • 174 citations
Amplification of the int-2 gene in primary human breast tumors.
1988 • 172 citations
Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis
1991 • 172 citations
Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Histopathologic, demographic, and biochemical correlations and relationship to endocrine response and survival
1990 • 171 citations
STUDIES WITH TRITIUM-LABELLED HEXŒSTROL IN ADVANCED BREAST CANCER
1961 • 167 citations
Karnofsky memorial lecture. Conceptual and practical advances in the management of breast cancer.
1989 • 166 citations
Low nm23 protein expression in infiltrating ductal breast carcinomas correlates with reduced patient survival.
1991 • 166 citations
Mutations in the p53 gene in primary human breast cancers.
1991 • 165 citations
The immunocytochemical detection of axillary micrometastases in breast cancer
1984 • 157 citations
Correlation of Pretreatment Proliferative Activity of Breast Cancer With the Response to Cytotoxic Chemotherapy
1989 • 156 citations
correlation between histologic grade of malignancy and copy number of c-erbb-2 gene in breast carcinoma. A retrospective analysis of 176 cases
1990 • 152 citations
Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer. An immunohistochemical study
1990 • 150 citations
Relation between p53 overexpression and established prognostic factors in breast cancer.
1991 • 149 citations
Distribution of an estrogen-induced protein with a molecular weight of 24,000 in normal and malignant human tissues and cells.
1983 • 148 citations
Analysis of reproducibility of subjective grading systems for breast carcinoma.
1979 • 144 citations
Proto-oncogene abnormalities in human breast cancer: correlations with anatomic features and clinical course of disease.
1987 • 143 citations
Pathologic correlates of survival in 378 lymph node-negative infiltrating ductal breast carcinomas. Mitotic count is the best single predictor
1991 • 143 citations
SIGNIFICANCE OF INTERNAL MAMMARY LYMPH NODE METASTASES IN BREAST CANCER
1971 • 142 citations
P-Glycoprotein expression in treated and untreated human breast cancer
1989 • 133 citations
Varying Degrees of Malignancy in Cancer of the Breast
1925 • 131 citations
Haptoglobin-Related Protein (Hpr) Epitopes in Breast Cancer as a Predictor of Recurrence of the Disease
1989 • 129 citations
Significance of quantitative assessment of estrogen receptors for endocrine therapy in advanced breast cancer
1977 • 129 citations
Immunohistochemical analysis of P-glycoprotein expression correlated with chemotherapy resistance in locally advanced breast cancer
1990 • 127 citations
pS2 expression and response to hormonal therapy in patients with advanced breast cancer.
1991 • 123 citations
The prognostic significance of nuclear DNA content in invasive breast cancer – a study with long-term follow-up
1989 • 120 citations
Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer.
1993 • 118 citations
Predictive value of nuclear DNA content in breast cancer in relation to clinical and morphologic factors. A retrospective study of 227 consecutive cases
1988 • 117 citations
The 1982 national survey of carcinoma of the breast in the United States by the American College of Surgeons.
1984 • 115 citations
Quantitative estrogen receptor analyses: The response to endocrine and cytotoxic chemotherapy in human breast cancer and the disease-free interval
1980 • 111 citations
DNA index, S-phase fraction, histological grade and prognosis in breast cancer
1990 • 110 citations
The relation of flow cytometry to clinical and biologic characteristics in women with node negative primary breast cancer
1989 • 105 citations
Pathologic findings from the national surgical adjuvant breast project (protocol no. 4) vi. discriminants for five-year treatment failure
1980 • 105 citations
Pathologic findings from the national surgical adjuvant breast and bowel projects (NSABP) prognostic discriminants for 8-year survival for node-negative invasive breast cancer patients
1990 • 101 citations
Correlation of primary breast cancer histopathology and estrogen receptor content
1981 • 101 citations
Estrogen receptors in human breast cancer tissue
1972 • 100 citations
The morphometric prognostic index is the strongest prognosticator in premenopausal lymph node-negative and lymph node-positive breast cancer patients
1991 • 99 citations
THE ASSESSMENT OF HISTOLOGICAL DIFFERENTIATION IN BREAST CANCER*
1984 • 98 citations
DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-Phase fraction to outcome of patients in NSABP B-04
1991 • 97 citations
The value of estrogen and progesterone receptor determinations in advanced breast cancer. Estrogen receptor level but not progesterone receptor level correlates with response to tamoxifen
1991 • 92 citations
Current status of Milan adjuvant chemotherapy trials for node-positive and node-negative breast cancer.
1986 • 87 citations
Electrophoretic analysis of 248 clinical breast cancer specimens for P-glycoprotein overexpression or gene amplification.
1989 • 86 citations
Further Studies on Prognosis of Breast Carcinoma
1950 • 85 citations
Estrogen and progesterone receptors in cytology: A comprehensive review
1992 • 84 citations
Prognostic significance of flow cytometric DNA analysis in node-negative breast cancer patients
1990 • 84 citations
Practical breast carcinoma cell kinetics: Review and update
1984 • 82 citations
Prognostic significance of image morphometric microvessel enumeration in breast carcinoma.
1993 • 81 citations
Oestrogen Receptor in Human Breast Cancer Tissue and Response to Endocrine Therapy
1973 • 80 citations
Prognostic factors in recurrent breast cancer: relationships to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy grading
1990 • 80 citations
Tritiated Thymidine Labeling Index and Response in Human Breast Cancer
1979 • 79 citations
Carcinoma of the breast.The prognostic significance of extranodal extension of axillary disease
1977 • 77 citations
p53 mutations and overexpression in locally advanced breast cancers
1994 • 74 citations
A prospective study of the prognostic value of cathepsin D levels in breast cancer cytosol
1993 • 74 citations
Predictability of Response to Endocrine Ablation in Advanced Breast Carcinoma
1973 • 73 citations
Factors predicting for response, time to treatment failure, and survival in women with metastatic breast cancer treated with DAVTH: a prospective Eastern Cooperative Oncology Group study.
1991 • 72 citations
DNA analysis by flow cytometry, response to endocrine treatment and prognosis in advanced carcinoma of the breast
1987 • 70 citations
Prognostic value of DNA ploidy and S-phase fraction in relation to estrogen receptor content and clinicopathological variables in primary breast cancer
1989 • 70 citations
Is DNA ploidy an independent prognostic indicator in infiltrative node-negative breast adenocarcinoma?
1990 • 66 citations
Flow cytometry in primary breast cancer: improving the prognostic value of the fraction of cells in the S-phase by optimal categorisation of cut-off levels
1990 • 62 citations
Cathepsin D in invasive ductal NOS breast carcinoma as defined by immunohistochemistry. No correlation with survival at 5 years.
1992 • 61 citations
Elevated ras oncogene expression correlates with lymph node metastases in breast cancer patients.
1986 • 60 citations
Prognostic value of total cathepsin D in breast tumors
1991 • 55 citations
Cathepsin D concentration in breast cancer cytosols: correlation with biochemical, histological, and clinical findings
1991 • 54 citations
Effects of tamoxifen on estrogen and progesterone receptors in human breast cancer.
1981 • 53 citations
Use of monoclonal antibody for assessment of estrogen receptor content in fine-needle aspiration biopsy specimen from patients with breast cancer.
1989 • 51 citations
Prognostic and therapeutic significance of pathological features of breast cancer.
1986 • 50 citations
Correlations between certain biochemical properties of breast cancer and response to therapy: A preliminary report
1974 • 50 citations
Prognostic relevance of cathepsin D versus oestrogen receptors in node negative breast cancers
1991 • 47 citations
Histological grade, elastosis, DNA ploidy and the response to chemotherapy of breast cancer
1987 • 44 citations
Improvement of the Quantification of Estrogen and Progesterone Receptors in Paraffin-Embedded Tumors by Image Analysis
1993 • 44 citations
Vascular Relationships of Tumor and Host*
2015 • 44 citations
Tumor factors predicting for prognosis in metastatic breast cancer: The presence of P24 predicts for response to treatment and duration of survival
1990 • 41 citations
The significance of supraclavicular fossa node recurrence after radical mastectomy
1986 • 40 citations
Relationships between oestrogen receptor, epidermal growth factor receptor, ER‐D5, and P24 oestrogen regulated protein in human breast cancer
1988 • 36 citations
Receptor and centriole pathways of steroid action in normal and neoplastic cells.
1978 • 35 citations
Bilateral adrenalectomy in metastatic mammary cancer:An analysis of sixty-four cases
1969 • 35 citations
Appearance and detection of multiple copies of the mdr‐1 gene in clinical samples of mammary carcinoma
1992 • 34 citations
Immunohistochemical Detection of Cathepsin D in T2N0M0 Breast Carcinoma
1994 • 31 citations
The prognostic significance of palpable lymph nodes in cancer of the breast
1969 • 31 citations
Immunohistochemical and other features of breast carcinomas presenting clinically compared with those detected by cancer screening
1991 • 29 citations
Immunocytochemical Analysis of Progesterone Receptors in Breast Cancer
1991 • 28 citations
Biological factors of prognostic significance in locally advanced breast cancer
1994 • 26 citations
Steroid-hormone receptors in nonpalpable and more advanced stages of breast cancer. A contribution to the biology and natural history of carcinoma of the female breast
1990 • 25 citations
Prognostic factors for recurrence and survival in axillary node-negative breast cancer
1989 • 25 citations
Evaluation of Rotter's lymph nodes in radical mastectomy specimens as a guide to prognosis
1965 • 23 citations
Specific protein synthesis regulated by estrogen in human breast cancer
1981 • 23 citations
Immunohistochemical localisation of pS2 protein in ductal carcinoma in situ and benign lesions of the breast
1993 • 22 citations
Immunocytochemical localization of estrogen and progesterone receptors in imprint preparations of breast carcinomas
1992 • 22 citations
Prognostic Factors in Node-Negative Breast Cancer
1992 • 20 citations
An observation of DNA ploidy, histological grade, and immunoreactivity for tumour‐related antigens in primary and metastatic breast carcinoma
1989 • 20 citations
Expression of Haptoglobin-related Protein in Primary and Metastatic Breast Cancers: A Longitudinal Study of 48 Fatal Tumors
1991 • 19 citations
Scalene node biopsy in locally advanced primary breast cancer of questionable operability
1964 • 18 citations
Prognostic Factors in Primary Breast Cancer
1986 • 18 citations
Response to second-line hormone treatment for advanced breast cancer. Predictive value of ploidy determination
1990 • 17 citations
Influence of S-phase fraction on metastatic pattern and post-recurrence survival in a randomized mammography screening trial
1989 • 15 citations
Use of monoclonal antibody for assessment of estrogen and progesterone receptors in malignant effusions
1992 • 14 citations
Interlaboratory Comparison of Estrogen Receptor Analysis in Paraffin Sections by a Monoclonal Antibody to Estrophilin (H222)
1993 • 14 citations
Tumor grade in the prognosis of breast cancer.
1970 • 14 citations
The significance of hyperemia around tumor implants.
1946 • 12 citations
Standardization of immunobioassays as surrogate endpoints.
1994 • 11 citations
Metastatic Pattern and DNA Ploidy in Stage IV Breast Cancer at Initial Diagnosis
1993 • 7 citations
Multidrug Resistance Phenotype: A Potential Marker of Chemotherapy Resistance in Breast Cancer?
1993 • 6 citations
Cited By (0)
No citing papers found in database